Long-term efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis sustained for three years: Results of a randomized controlled phase 3 study (UNCOVER-3)

2018 ◽  
Vol 79 (3) ◽  
pp. AB180
Keyword(s):  
Plaque Psoriasis ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Severe Plaque Psoriasis ◽  
Randomized Controlled ◽  
Term Efficacy

scholarly journals Long-term efficacy and safety of secukinumab in Japanese patients with moderate to severe plaque psoriasis: 3-year results of a double-blind extension study

2019 ◽  
Vol 46 (3) ◽  
pp. 186-192 ◽  
Author(s):  
Yukari Okubo ◽  
Mamitaro Ohtsuki ◽  
Akimichi Morita ◽  
Masako Yamaguchi ◽  
Tomohiro Shima ◽  
...  
Keyword(s):  
Plaque Psoriasis ◽  
Japanese Patients ◽  
Extension Study ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Severe Plaque Psoriasis ◽  
Term Efficacy

Long-term Efficacy and Safety of Brodalumab in Patients With Psoriasis Disease Duration <10 and ≥10 Years: Analysis of Two Phase 3 Studies

2019 ◽  
Vol 3 ◽  
pp. S25
Author(s):  
Benjamin Ehst ◽  
George Han ◽  
Scott Guenthner ◽  
Kimberly Eads ◽  
Abby Jacobson
Keyword(s):  
Disease Duration ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Two Phase ◽  
Term Efficacy

Abstract not available.

Sign in / Sign up

Export Citation Format

Share Document